Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Erez Israeli

Tracked across 3 events · 36 articles · First seen May 28, 2026 · Last active Sep 10, 2026

Sentiment
-13
Attention
4
Events
3
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 -20
Regulatory
Pomerantz LLP is investigating claims on behalf of investors of Abbott Laboratories Limited regarding potential securities fraud or other unlawful business practices. The investigation stems from Dr. Reddy's announcement on July 22, 2026 of its…
Impact: CEO of Dr. Reddy's, quoted explaining the earnings miss and semaglutide-related challenges; his statements are central to the investigation.
Aug 25, 2026 · 6 articles
2 10
Business
Impact: Erez Israeli, CEO of Abbott Laboratories, attended the closing bell ceremony, representing the company's leadership.
May 28, 2026 · 7 articles
4 -30
Business
Impact: CEO; explained semaglutide issue and maintained FY27 outlook, but his earlier margin statements are under investigation.
Jul 09, 2026 · 23 articles
ERGEN INTELLIGENCE
Track Erez Israeli live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.